The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

YOUR MISSION

The Josep Carreras Leukaemia Research Institute (IJC) is seeking an experienced Project Manager to coordinate a diverse array of local and international projects and scientific programs.

One of these projects, is a five-year, multimillion-dollar international research collaboration focused on follicular lymphoma. This project involves coordinating research centers and stakeholders worldwide and is funded by the RAFL Synergistic Team Award from The Leukemia & Lymphoma Society and the Institute for Follicular Lymphoma Innovation. In addition to this flagship initiative, the Project Manager will also support the coordination of other research projects aligned with the scientific and translational goals of the Scientific Leader, contributing to the long-term sustainability and impact of this research program.

Main responsibilities

• Project coordination: Assist the Scientific Leader in the overall coordination of Dr. Melnick projects, ensuring alignment with objectives and that milestones are met. Develop and maintain tools to monitor KPIs, timelines, and budgets to facilitate coordination and support funder reporting.
• Stakeholder engagement: Facilitate communication and collaboration among international partners, including research institutions, funding bodies, and regulatory agencies. Organize periodic reviews and consortium meetings.
• Compliance and reporting: Ensure adherence to funding rules and award conditions across the projects. Coordinate subawards with participating institutions. Monitor budget execution, coordinate procurement, personnel hiring, and financial audits. Prepare progress and financial reports and project deliverables coordinate partner contribution and ensure timely submission.
• Project management: Liaise with internal and external contacts at participating institutions (e.g. research, finance, legal, technology transfer) to ensure compliance with ethics approvals, implementation of FAIR/GDPR-compliant Data Management Plans, publication of findings and dissemination of results, proper IP Management, adherence to open science principles, and coordinated public communication. Coordinate data and biospecimen transfers among international partners ensuring regulatory compliance.
• Risk management: Identify potential risks and develop mitigation strategies to ensure project continuity.
• Follow-on funding: Identify funding opportunities, support further proposal preparation and contribute to consortium building to secure next awards, ensuring program sustainability.
• Another transversal tasks when required.

WHAT WE NEED

• Bachelor’s degree or master’s degree in Life Sciences. PhD degree will be an asset.
• Five years minimum work experience in biomedical research-support, especially managing large international research collaborations.
• Thorough knowledge of international funding programmes and experience in grant writing and proposal development.

• Ability to work within tight deadlines and manage multiple projects simultaneously.
• Good knowledge of Office 365; advanced skills in Excel and Power BI will be an asset.

• Strong organizational, planning, and analytical skills, with attention to detail.
• Ability to work cooperatively and inclusively with others to achieve shared goals.

• Willingness to self-improve and grow knowledge and skills.
• Passion for our mission and to contribute to boosting the societal impact of cancer research.

WHAT WE OFFER

• Immediate incorporation.
• Full-time position (39h per week).
• This position is partially supported by funding from The Blood Cancer United and the Institute for Follicular Lymphoma Innovation (IFLI) through the Research Accelerator for Follicular Lymphoma (RAFL) Synergistic Team Award (SAT), under the ERADICATE Follicular Lymphoma Consortium grant.

• Measures to reconcile work and family life (flexible work schedule, teleworking, 23 working days of vacation and 11 days for personal matters).
• Flexible remuneration program (kindergarten).
• Training opportunities.
• Spanish/Catalan/English language courses, if required.

• Competitive salary commensurate with experience and qualifications.

Annual gross salary between 35000 – 40.000€.

• Join a highly collaborative team and engage in exciting projects.
• Work within a dynamic environment blending basic and clinical research.

• Enjoy the vibrant surroundings of the Barcelona metropolitan area, IJC headquarters located in nature.

DEADLINE

Please submit your application by 13/10/2025.

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.